123 related articles for article (PubMed ID: 36309848)
1. Effect of Genotype on the Pharmacokinetics and Bleeding Events of Direct Oral Anticoagulants: A Systematic Review and Meta-analysis.
Shi J; Wu T; Wu S; Chen X; Ye Q; Zhang J
J Clin Pharmacol; 2023 Mar; 63(3):277-287. PubMed ID: 36309848
[TBL] [Abstract][Full Text] [Related]
2. Effect of ABCB1 Genotypes on the Pharmacokinetics and Clinical Outcomes of New Oral Anticoagulants: A Systematic Review and Meta-analysis.
Xie Q; Xiang Q; Mu G; Ma L; Chen S; Zhou S; Hu K; Zhang Z; Cui Y; Jiang J
Curr Pharm Des; 2018; 24(30):3558-3565. PubMed ID: 30338730
[TBL] [Abstract][Full Text] [Related]
3. The effect of
Shao S; Hu L; Han Z; Hou K; Fang H; Zhang G; Feng Y; Huang L
Transl Androl Urol; 2020 Apr; 9(2):673-683. PubMed ID: 32420174
[TBL] [Abstract][Full Text] [Related]
4. CYP2C9*3(1075A > C), ABCB1 and SLCO1B1 genetic polymorphisms and gender are determinants of inter-subject variability in pitavastatin pharmacokinetics.
Zhou Q; Chen QX; Ruan ZR; Yuan H; Xu HM; Zeng S
Pharmazie; 2013 Mar; 68(3):187-94. PubMed ID: 23556337
[TBL] [Abstract][Full Text] [Related]
5. Pharmacogenetics of Bleeding and Thromboembolic Events in Direct Oral Anticoagulant Users.
Lähteenmäki J; Vuorinen AL; Pajula J; Harno K; Lehto M; Niemi M; van Gils M
Clin Pharmacol Ther; 2021 Sep; 110(3):768-776. PubMed ID: 34043814
[TBL] [Abstract][Full Text] [Related]
6. ABCB1 gene polymorphisms, ABCB1 haplotypes and ABCG2 c.421c > A are determinants of inter-subject variability in rosuvastatin pharmacokinetics.
Zhou Q; Ruan ZR; Yuan H; Xu DH; Zeng S
Pharmazie; 2013 Feb; 68(2):129-34. PubMed ID: 23469685
[TBL] [Abstract][Full Text] [Related]
7. The impact of ABCB1 and CES1 polymorphisms on dabigatran pharmacokinetics and pharmacodynamics in patients with atrial fibrillation.
Ji Q; Zhang C; Xu Q; Wang Z; Li X; Lv Q
Br J Clin Pharmacol; 2021 May; 87(5):2247-2255. PubMed ID: 33179295
[TBL] [Abstract][Full Text] [Related]
8. Association between Genetic Polymorphisms and Bleeding in Patients on Direct Oral Anticoagulants.
Yoon HY; Song TJ; Yee J; Park J; Gwak HS
Pharmaceutics; 2022 Sep; 14(9):. PubMed ID: 36145636
[No Abstract] [Full Text] [Related]
9. Effect of Sex, Use of Pantoprazole and Polymorphisms in SLC22A1, ABCB1, CES1, CYP3A5 and CYP2D6 on the Pharmacokinetics and Safety of Dabigatran.
Zubiaur P; Saiz-Rodríguez M; Ochoa D; Navares-Gómez M; Mejía G; Román M; Koller D; Soria-Chacartegui P; Almenara S; Abad-Santos F
Adv Ther; 2020 Aug; 37(8):3537-3550. PubMed ID: 32564268
[TBL] [Abstract][Full Text] [Related]
10. The impact of
Sychev DA; Levanov AN; Shelekhova TV; Bochkov PO; Denisenko NP; Ryzhikova KA; Mirzaev KB; Grishina EA; Gavrilov MA; Ramenskaya GV; Kozlov AV; Bogoslovsky T
Pharmgenomics Pers Med; 2018; 11():127-137. PubMed ID: 30100750
[TBL] [Abstract][Full Text] [Related]
11. The Impact of ABCB1 and CES1 Polymorphisms on Dabigatran Pharmacokinetics in Healthy Chinese Subjects.
Liu Y; Yang C; Qi W; Pei Z; Xue W; Zhu H; Dong M; Guo Y; Cong D; Wang F
Pharmgenomics Pers Med; 2021; 14():477-485. PubMed ID: 33935512
[TBL] [Abstract][Full Text] [Related]
12. Direct Oral Anticoagulants Compared with Vitamin K Antagonists for Left Ventricular Thrombus: A Systematic Review and Meta-analysis.
Fang S; Zhu BZ; Yang F; Wang Z; Xiang Q; Gong YJ
Curr Pharm Des; 2022; 28(23):1902-1910. PubMed ID: 35400334
[TBL] [Abstract][Full Text] [Related]
13. Impact of ABCB1, ABCG2, and CYP3A5 polymorphisms on plasma trough concentrations of apixaban in Japanese patients with atrial fibrillation.
Ueshima S; Hira D; Fujii R; Kimura Y; Tomitsuka C; Yamane T; Tabuchi Y; Ozawa T; Itoh H; Horie M; Terada T; Katsura T
Pharmacogenet Genomics; 2017 Sep; 27(9):329-336. PubMed ID: 28678049
[TBL] [Abstract][Full Text] [Related]
14. Different Coagulation Indicators in Predicting Clinical Outcomes for Patients With Direct Oral Anticoagulants: A Systematic Review and Meta-analysis.
Liu Z; Zhang H; Xie Q; Mu G; Zhou S; Wang Z; Wang Z; Jiang J; Xiang Q; Cui Y
Clin Ther; 2020 Oct; 42(10):2066-2081.e9. PubMed ID: 32900534
[TBL] [Abstract][Full Text] [Related]
15. Influence of ABCB1, CYP3A5 and CYP3A4 gene polymorphisms on prothrombin time and the residual equilibrium concentration of rivaroxaban in patients with non-valvular atrial fibrillation in real clinical practice.
Sychev DA; Sokolov AV; Reshetko OV; Fisenko VP; Sychev IN; Grishina EA; Bochkov PO; Shevchenko RV; Abdullaev SP; Denisenko NP; Ivashchenko DV; Sozaeva ZA; Kachanova AA
Pharmacogenet Genomics; 2022 Dec; 32(9):301-307. PubMed ID: 36256705
[TBL] [Abstract][Full Text] [Related]
16. The impact of CYP4F2, ABCB1, and GGCX polymorphisms on bleeding episodes associated with acenocoumarol in Russian patients with atrial fibrillation.
Sychev DA; Rozhkov AV; Kazakov RE; Ananichuk AV
Drug Metab Pers Ther; 2016 Sep; 31(3):173-8. PubMed ID: 27662649
[TBL] [Abstract][Full Text] [Related]
17. Influence of ABCB1 and CYP3A5 genetic polymorphisms on the pharmacokinetics of quetiapine in healthy volunteers.
Kim KA; Joo HJ; Lee HM; Park JY
Pharmacogenet Genomics; 2014 Jan; 24(1):35-42. PubMed ID: 24240480
[TBL] [Abstract][Full Text] [Related]
18. The Effect of ABCB1 C3435T Polymorphism on Cyclosporine Dose Requirements in Kidney Transplant Recipients: A Meta-Analysis.
Lee J; Wang R; Yang Y; Lu X; Zhang X; Wang L; Lou Y
Basic Clin Pharmacol Toxicol; 2015 Aug; 117(2):117-25. PubMed ID: 25536375
[TBL] [Abstract][Full Text] [Related]
19. The effect of ABCB1 C3435T polymorphism on pharmacokinetics of tacrolimus in liver transplantation: a meta-analysis.
Liu YY; Li C; Cui Z; Fu X; Zhang S; Fan LL; Ma J; Li G
Gene; 2013 Dec; 531(2):476-88. PubMed ID: 24042126
[TBL] [Abstract][Full Text] [Related]
20. Using oral anticoagulants among chronic kidney disease patients to prevent recurrent venous thromboembolism: A systematic review and meta-analysis.
Alhousani M; Malik SU; Abu-Hashyeh A; Poznanski NJ; Al-Hasan S; Roth DF; Alsharedi M; Mustafa B
Thromb Res; 2021 Feb; 198():103-114. PubMed ID: 33310644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
